Product image of Medipam (Diazepam) supplied by GNH India

Medipam

Active Ingredient:
Diazepam
Origin:
EU

Medipam (Diazepam)

Diazepam, the active ingredient in Medipam, is a benzodiazepine presented as an oral tablet for oral use. It acts on the central nervous system to produce anxiolytic, anticonvulsant, muscle‑relaxant, and sedative effects, making it useful in the management of anxiety disorders, various seizure types, muscle spasm, alcohol withdrawal syndrome, and procedural sedation prior to diagnostic or therapeutic interventions.

GNH India supplies Medipam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Holsten Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Diazepam is a benzodiazepine that modulates GABA‑A receptors and is employed in several clinical situations.

  • Anxiety disorders: reduces excessive anxiety and tension in adults.
  • Seizure disorders: controls acute seizures and provides adjunct therapy for epilepsy.
  • Muscle spasm: relaxes skeletal muscle tone associated with spasticity.
  • Alcohol withdrawal syndrome: alleviates withdrawal symptoms and prevents complications.
  • Sedation before procedures: provides short‑acting sedation for diagnostic or minor surgical procedures.

How It Works

  • Diazepam binds to a specific site on the gamma‑aminobutyric acid type A (GABA‑A) receptor complex, acting as a positive allosteric modulator. This enhances the frequency of chloride channel opening in response to GABA, increasing neuronal chloride influx and hyperpolarization. The resulting amplified inhibitory neurotransmission reduces neuronal excitability, producing anxiolytic, anticonvulsant, muscle‑relaxant, and sedative effects.

Side Effects

Diazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Drowsiness
  • Fatigue
  • Muscle weakness
  • Ataxia
  • Dizziness
  • Blurred vision

Serious or Rare Side Effects

  • Respiratory depression
  • Severe hypotension
  • Dependence or addiction
  • Paradoxical reactions such as agitation
  • Severe skin reactions (e.g., Stevens‑Johnson syndrome)
  • Hepatic dysfunction or jaundice

Precautions & Warnings

When prescribing diazepam, clinicians should consider several safety precautions.

  • Pregnancy: Category D; use only when benefits outweigh potential fetal risks.
  • Elderly patients: increased sensitivity to sedation and falls; start with lower doses.
  • History of substance abuse: risk of dependence; monitor closely.
  • Hepatic impairment: reduced metabolism may increase plasma levels; adjust dosage.
  • Concomitant CNS depressants: may potentiate sedation and respiratory depression.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Avoid Interactions

Diazepam interacts with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Opioids, alcohol, or other CNS depressants: can cause profound sedation and respiratory depression.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): markedly increase diazepam plasma concentrations.
  • Concurrent use with other benzodiazepines: risk of excessive sedation and cumulative effects.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce therapeutic levels.
  • Anticholinergic agents: may enhance cognitive impairment.
  • Antihistamines: can increase sedation.
  • Oral contraceptives: may alter hormone levels; monitor efficacy.
  • Antidepressants (e.g., SSRIs): may increase sedation.

Frequently Asked Questions

Medipam, containing diazepam, is prescribed for anxiety disorders, various seizure types, muscle spasm, alcohol withdrawal syndrome, and as a short‑acting sedative before diagnostic or minor surgical procedures. These uses reflect its anxiolytic, anticonvulsant, muscle‑relaxant, and sedative properties.

Diazepam binds to a specific site on the GABA‑A receptor complex, acting as a positive allosteric modulator. By enhancing GABA‑mediated chloride influx, it increases neuronal inhibition, which reduces excitability and produces calming, anticonvulsant, muscle‑relaxing, and sedative effects.

The dose of Medipam is individualized by the prescribing clinician based on the patient’s condition, age, liver function, and other factors. Only a qualified healthcare professional should determine the appropriate dosage and regimen.

Diazepam is classified as Pregnancy Category D, indicating potential risk to the fetus. It should be used during pregnancy only when the therapeutic benefit justifies the risk. Diazepam passes into breast milk, so breastfeeding mothers should discuss alternatives with their healthcare provider.

To request Medipam, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Compared with other benzodiazepines, diazepam has a relatively long half‑life and a rapid onset of action, making it useful for both acute and maintenance therapy. Its broad therapeutic profile includes seizure control and muscle relaxation, whereas some alternatives may be more selective for anxiety alone.

Medipam should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and store them out of reach of children.

Medipam is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include respiratory depression, severe hypotension, dependence or addiction, paradoxical reactions such as agitation or aggression, severe skin reactions, and hepatic dysfunction. Patients should be monitored closely for these events, especially when used with other CNS depressants.

Medipam is contraindicated in individuals with known hypersensitivity to diazepam or other benzodiazepines, severe acute narrow‑angle glaucoma, and in patients who are currently intoxicated with alcohol or other CNS depressants. Caution is also advised for those with severe respiratory insufficiency or uncontrolled severe liver disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Diazepam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT